A MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL OF VONOPRAZAN VERSUS PPI BASED 7-DAY TRIPLE THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION

被引：0
|
作者：
Sue, Soichiro
Kuwashima, Hirohumi
Arima, Isao
Ogushi, Marina
Nakao, Satoshi
Naito, Makoto
Komatu, Kazuto
Yamada, Hiroaki
Kaneko, Hiroaki
Tamura, Toshihide
Sasaki, Tomohiko
Kondo, Masaaki
Shibata, Wataru
Maeda, Shin
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31131-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1201
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [1] An open-label, multicenter, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for Helicobacter pylori infection
    Tamaki, Hiroyuki
    Morita, Masahiro
    Omura, Akina
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 36 - 36
  • [2] OPEN-LABEL RANDOMIZED CONTROLLED TRIAL OF VONOPRAZAN AND ESOMEPRAZOLE IN FIRST-LINE TRIPLE THERAPY AGAINST HELICOBACTER PYLORI INFECTION
    Tamaki, Hiroyuki
    Morita, Masahiro
    Noda, Teruyo
    Izuta, Masako
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S248 - S248
  • [3] AN OPEN-LABEL, MULTI-CENTER, RANDOMIZED, SUPERIORITY TRIAL OF VONOPRAZAN VERSUS ESOMEPRAZOLE AS PART OF FIRST-LINE TRIPLE THERAPY FOR HELICOBACTER PYLORI INFECTION
    Tamaki, Hiroyuki
    Noda, Teruyo
    Morita, Masahiro
    Omura, Akina
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S89 - S89
  • [4] Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
    Liou, Jyh-Ming
    Chen, Chieh-Chang
    Chen, Mei-Jyh
    Chen, Chien-Chuan
    Chang, Chi-Yang
    Fang, Yu-Jen
    Lee, Ji-Yuh
    Hsu, Shih-Jer
    Luo, Jiing-Chyuan
    Chang, Wen-Hsiung
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Tseng, Ping-Huei
    Wang, Hsiu-Po
    Yang, Ueng-Cheng
    Shun, Chia-Tung
    Lin, Jaw-Town
    Lee, Yi-Chia
    Wu, Ming-Shiang
    [J]. LANCET, 2013, 381 (9862): : 205 - 213
  • [5] Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
    Lee, Hyuk
    Kim, Beom Jin
    Kim, Sang Gyun
    Kim, Jin Il
    Choi, Il Ju
    Lee, Yong Chan
    Kim, Jae G.
    Kim, Jae J.
    [J]. TRIALS, 2017, 18
  • [6] Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
    Hyuk Lee
    Beom Jin Kim
    Sang Gyun Kim
    Jin Il Kim
    Il Ju Choi
    Yong Chan Lee
    Jae G. Kim
    Jae J. Kim
    [J]. Trials, 18
  • [7] Comparison of metronidazole versus clarithromycin in first-line vonoprazan-based triple therapy for Helicobacter pylori: A multicenter randomized trial in Japan
    Sue, Soichiro
    Oka, Hiroyuki
    Kunishi, Yosuke
    Suzuki, Yuichi
    Suzuki, Shingo
    Kaneko, Takashi
    Komatsu, Kazuo
    Naito, Makoto
    Kato, Yoshio
    Sasaki, Tomohiko
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Kondo, Masaaki
    Maeda, Shin
    [J]. JGH OPEN, 2024, 8 (04):
  • [8] CLARITHROMYCIN VERSUS METRONIDAZOLE CONTAINING FIRST-LINE VONOPRAZAN BASED TRIPLE THERAPY FOR HELICOBACTER PYLORI: A MULTICENTER, PROSPECTIVE, RANDOMIZED TRIAL IN JAPAN
    Sue, Soichiro
    Arima, Isao
    Hao, Yoshiteru
    Suzuki, Yuichi
    Suzuki, Shingo
    Kaneko, Takashi
    Suzuki, Yoshimasa
    Oka, Hiroyuki
    Amano, Hitoshi
    Ishida, Ayaka
    Mitsui, Tomohiro
    Nakayama, Sae
    Ogushi, Katsuaki
    Kusaka, Eriko
    Kunishi, Yosuke
    Okazaki, Hiroshi
    Komatu, Kazuto
    Naito, Makoto
    Kato, Yoshio
    Shibata, Wataru
    Sasaki, Tomohiko
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Kondo, Masaaki
    Maeda, Shin
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S535 - S535
  • [9] Berberine-, Allicin- or Clarithromycin-Based Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection: an Open-Label, Randomized Trial
    Zhang, Xiaomei
    Yang, Yunsheng
    Gang, Sun
    Yang, Chao
    Lu, Mingliang
    Zhi, Junli
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S398 - S398
  • [10] EFFICACY OF 7-DAY AND 10-DAY OF VAB (VONOPRAZAN, AMOXICILLIN, AND BISMUTH SUBSALICYLATE) VERSUS 14-DAY STANDARD TRIPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
    Phetkee, Thitiwat
    Anansawat, Veerayut
    Suksamai, Anuchit
    Songserm, Sukhum
    Yongwatana, Kachonsak
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S375 - S376
12345